
Company valuation, historical trends, and peer comparisons.
According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 148.83M. This represents a change of 89.86% compared to the average of 78.39M of the last 4 quarters.
The mean historical Enterprise Value of Actinogen Medical Limited over the last ten years is 65.74M. The current 148.83M Enterprise Value has changed 126.37% with respect to the historical average. Over the past ten years (40 quarters), ATGGF's Enterprise Value was at its highest in in the December 2021 quarter at 261.95M. The Enterprise Value was at its lowest in in the December 2024 quarter at -21846962.88.
Average
65.74M
Median
59.00M
Minimum
2.60M
Maximum
166.99M
Discovering the peaks and valleys of Actinogen Medical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 751.58%
Maximum Annual Enterprise Value = 166.99M
Minimum Annual Increase = -88.94%
Minimum Annual Enterprise Value = 2.60M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 91.34M | 65.19% |
| 2025 | 55.29M | -58.17% |
| 2024 | 132.20M | 110.83% |
| 2023 | 62.70M | -8.43% |
| 2022 | 68.48M | -58.99% |
| 2021 | 166.99M | 751.58% |
| 2020 | 19.61M | 655.08% |
| 2019 | 2.60M | -88.94% |
| 2018 | 23.49M | -32.41% |
| 2017 | 34.75M | -17.86% |
The current Enterprise Value of Actinogen Medical Limited (ATGGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
92.94M
5-year avg
82.00M
10-year avg
65.74M
Actinogen Medical Limited’s Enterprise Value is greater than Alterity Therapeutics Limited (27.50M), greater than Neurizon Therapeutics Limited (40.49M), less than Neuren Pharmaceuticals Limited (2.89B), greater than Argenica Therapeutics Ltd (6.48M), greater than Nyrada Inc. (104.04M), greater than Invex Therapeutics Ltd (6.00M), greater than NeuroScientific Biopharmaceuticals Limited (18.50M), greater than Argent BioPharma Limited (12.04M), greater than Arovella Therapeutics Limited (46.69M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 27.50M | $64.62M | |
| 40.49M | $49.87M | |
| 2.89B | $2.91B | |
| 6.48M | $12.85M | |
| 104.04M | $112.43M | |
| 6.00M | $7.52M | |
| 18.50M | $21.04M | |
| 12.04M | $2.59M | |
| 46.69M | $61.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Actinogen Medical Limited's Enterprise Value?
What is the highest Enterprise Value for Actinogen Medical Limited (ATGGF)?
What is the 3-year average Enterprise Value for Actinogen Medical Limited (ATGGF)?
What is the 5-year average Enterprise Value for Actinogen Medical Limited (ATGGF)?
How does the current Enterprise Value for Actinogen Medical Limited (ATGGF) compare to its historical average?